Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy
Authors:
- Usha PandeyUPUsha Pandey
- Remani B. ManolkarRMRemani B. Manolkar
- Ashutosh DashADAshutosh Dash
- Meera VenkateshMVMeera Venkatesh
- M.R. Ambikalmajan PillaiMPM.R. Ambikalmajan Pillai
- 1 February 2008
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 35 (2) , 245-253
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Radioimmunotherapy for B-cell lymphoma: Y90 ibritumomab tiuxetan and I131 tositumomabOncogene, 2007
- Radiolabelled Regulatory Peptides for Imaging and TherapyAnti-Cancer Agents in Medicinal Chemistry, 2007
- Long‐term responses in patients with recurring or refractory B‐cell non‐Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetanCancer, 2007
- Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratioJournal of Translational Medicine, 2007
- Regional Yttrium-90 Microsphere Treatment of Surgically Unresectable and Chemotherapy-Refractory Metastatic Liver CarcinomaCancer Biotherapy and Radiopharmaceuticals, 2006
- Radioimmunotherapy of brain tumorNeurological Research, 2006
- Zevalin: the first radioimmunotherapy approved for the treatment of lymphomaExpert Review of Anticancer Therapy, 2002
- The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapyCritical Reviews in Oncology/Hematology, 2001
- A new 90Sr/90Y radioisotope generatorThe International Journal of Applied Radiation and Isotopes, 1978
- Preparation and Half Life of Carrier-Free Yttrium-90Analytical Chemistry, 1955